Matches in SemOpenAlex for { <https://semopenalex.org/work/W2214973932> ?p ?o ?g. }
- W2214973932 endingPage "58" @default.
- W2214973932 startingPage "47" @default.
- W2214973932 abstract "Sarcopenia is an age-related muscle condition which is frequently a precursor of frailty, mobility disability and premature death. It has a high prevalence in older populations and presents a considerable social and economic burden. Potential treatments are under development but, as yet, no guidelines support regulatory studies for new drugs to manage sarcopenia. The objective of this position paper is therefore to suggest a set of potential endpoints and target population definitions to stimulate debate and progress within the medico-scientific and regulatory communities. A multidisciplinary expert working group was hosted by the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, which reviewed and discussed the recent literature from a perspective of clinical experience and guideline development. Relevant parallels were drawn from the development of definition of osteoporosis as a disease and clinical assessment of pharmaceutical treatments for that indication. A case-finding decision tree is briefly reviewed with a discussion of recent prevalence estimations of different relevant threshold values. The selection criteria for patients in regulatory studies are discussed according to the aims of the investigation (sarcopenia prevention or treatment) and the stage of project development. The possible endpoints of such studies are reviewed and a plea is made for the establishment of a core outcome set to be used in all clinical trials of sarcopenia. The current lack of guidelines for the assessment of new therapeutic treatments for sarcopenia could potentially hinder the delivery of effective medicines to patients at risk." @default.
- W2214973932 created "2016-06-24" @default.
- W2214973932 creator A5010987800 @default.
- W2214973932 creator A5013907113 @default.
- W2214973932 creator A5014231492 @default.
- W2214973932 creator A5015962886 @default.
- W2214973932 creator A5024756058 @default.
- W2214973932 creator A5024962441 @default.
- W2214973932 creator A5029800837 @default.
- W2214973932 creator A5030786310 @default.
- W2214973932 creator A5037004738 @default.
- W2214973932 creator A5038085370 @default.
- W2214973932 creator A5039171060 @default.
- W2214973932 creator A5044831604 @default.
- W2214973932 creator A5046313120 @default.
- W2214973932 creator A5050173865 @default.
- W2214973932 creator A5051269948 @default.
- W2214973932 creator A5063933818 @default.
- W2214973932 creator A5071342393 @default.
- W2214973932 creator A5072491798 @default.
- W2214973932 creator A5072667634 @default.
- W2214973932 creator A5075226333 @default.
- W2214973932 creator A5080778810 @default.
- W2214973932 creator A5082866696 @default.
- W2214973932 creator A5086010333 @default.
- W2214973932 date "2015-12-30" @default.
- W2214973932 modified "2023-10-10" @default.
- W2214973932 title "Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia" @default.
- W2214973932 cites W1500093205 @default.
- W2214973932 cites W1513691653 @default.
- W2214973932 cites W1541923384 @default.
- W2214973932 cites W1547114701 @default.
- W2214973932 cites W1570598499 @default.
- W2214973932 cites W1905308496 @default.
- W2214973932 cites W1908904713 @default.
- W2214973932 cites W1917806107 @default.
- W2214973932 cites W1921610072 @default.
- W2214973932 cites W1965927192 @default.
- W2214973932 cites W1970531992 @default.
- W2214973932 cites W1977946208 @default.
- W2214973932 cites W1986691314 @default.
- W2214973932 cites W1988574927 @default.
- W2214973932 cites W1997149183 @default.
- W2214973932 cites W2000448207 @default.
- W2214973932 cites W2001037763 @default.
- W2214973932 cites W2011885618 @default.
- W2214973932 cites W2017336804 @default.
- W2214973932 cites W2027214144 @default.
- W2214973932 cites W2033299724 @default.
- W2214973932 cites W2035521457 @default.
- W2214973932 cites W2035649540 @default.
- W2214973932 cites W2040645421 @default.
- W2214973932 cites W2041107146 @default.
- W2214973932 cites W2060090988 @default.
- W2214973932 cites W2063625194 @default.
- W2214973932 cites W2063690006 @default.
- W2214973932 cites W2064936259 @default.
- W2214973932 cites W2069189946 @default.
- W2214973932 cites W2074054173 @default.
- W2214973932 cites W2081427992 @default.
- W2214973932 cites W2096188544 @default.
- W2214973932 cites W2096657471 @default.
- W2214973932 cites W2097701643 @default.
- W2214973932 cites W2099091257 @default.
- W2214973932 cites W2099281324 @default.
- W2214973932 cites W2102902846 @default.
- W2214973932 cites W2103481948 @default.
- W2214973932 cites W2104357394 @default.
- W2214973932 cites W2106781062 @default.
- W2214973932 cites W2107490395 @default.
- W2214973932 cites W2108272307 @default.
- W2214973932 cites W2108712821 @default.
- W2214973932 cites W2109226190 @default.
- W2214973932 cites W2110768118 @default.
- W2214973932 cites W2110957605 @default.
- W2214973932 cites W2113800016 @default.
- W2214973932 cites W2114674166 @default.
- W2214973932 cites W2115598517 @default.
- W2214973932 cites W2119487122 @default.
- W2214973932 cites W2119958965 @default.
- W2214973932 cites W2123960494 @default.
- W2214973932 cites W2124238896 @default.
- W2214973932 cites W2124679472 @default.
- W2214973932 cites W2127873216 @default.
- W2214973932 cites W2129322604 @default.
- W2214973932 cites W2132273917 @default.
- W2214973932 cites W2134348840 @default.
- W2214973932 cites W2136392296 @default.
- W2214973932 cites W2145216788 @default.
- W2214973932 cites W2147848346 @default.
- W2214973932 cites W2148428406 @default.
- W2214973932 cites W2149017968 @default.
- W2214973932 cites W2151930815 @default.
- W2214973932 cites W2156131785 @default.
- W2214973932 cites W2156791190 @default.
- W2214973932 cites W2157300817 @default.
- W2214973932 cites W2158639922 @default.
- W2214973932 cites W2159296038 @default.